Tantum Verde, tablets 3 mg 20 pcs

Tonsillitis, Gum inflammation, Sore throat, Inflammation in the mouth, Angina, Pharyngitis, Stomatitis, LaryngitisSymptomatic therapy of pain syndrome of inflammatory diseases of the oral cavity and ENT (various etiology):

• Gingivitis, glossitis, stomatitis (including. After radiation and chemotherapy)
• pharyngitis, laryngitis, tonsillitis;
• candidosis of the oral mucosa (in combination therapy);
• calculous inflammation of the salivary glands;
• state after surgical interventions and trauma (tonsillectomy, jaw fractures);
• state after dental treatment and extraction;
• parodontosis.

In infectious and inflammatory diseases requiring systemic treatment, Tantum® Verde should be used in combination therapy.

Indications

Symptomatic treatment of pain syndrome of inflammatory diseases of the oral cavity and ENT organs (of various etiologies):
gingivitis, glossitis, stomatitis (including after radiation and chemotherapy);
pharyngitis, laryngitis, tonsillitis;
candidiasis of the oral mucosa (as part of combination therapy);
calculous inflammation of the salivary glands;
condition after surgical interventions and injuries (tonsillectomy, jaw fractures);
condition after treatment and tooth extraction;
periodontal disease.
For infectious and inflammatory diseases requiring systemic treatment, it is necessary to use Tantum® Verde as part of combination therapy.

Pharmacological effect

Local anesthetic, local anti-inflammatory.

Special instructions

When using the drug Tantum® Verde, hypersensitivity reactions may develop. In this case, it is recommended to stop treatment and consult a doctor to prescribe appropriate therapy. In a limited number of patients, the presence of ulcers in the throat and mouth may indicate a more serious condition. If symptoms persist for more than 3 days, you should consult your doctor.

The use of Tantum® Verde is not recommended in patients with hypersensitivity to acetylsalicylic acid or other NSAIDs.
The drug Tantum® Verde should be used with caution in patients with a history of bronchial asthma due to the possibility of developing bronchospasm while taking the drug.

The drug contains isomaltose, and therefore is not recommended for patients with hereditary fructose intolerance.
The use of the drug in children is possible only under adult supervision to avoid swallowing the tablet.
Influence on the ability to drive vehicles and machinery.
No effect.

Active ingredient

Benzydamine

Composition

Active substance:

benzydamine hydrochloride 3 mg.

Excipients:

isomaltose – 3183 mg;

levomenthol – 4 mg;

aspartame – 3.5 mg;

citric acid monohydrate – 2 mg;

mint flavor – 5 mg;

lemon flavoring – 1.5 mg;

quinoline yellow dye (E104) – 0.035 mg;

indigo carmine dye (E132) – 0.015 mg.

Contraindications

Hypersensitivity to benzydamine or other components of the drug;
fructose intolerance;
children under 6 years of age.
With caution: hypersensitivity to acetylsalicylic acid or other NSAIDs; bronchial asthma (including history).

Side Effects

WHO classification of the incidence of side effects: very often – ≥1/10; often – from ≥1/100 to <1/10; uncommon - from ≥1/1000 to <1/100; rarely - from ≥1/10000 to <1/1000; very rarely - <1/10000; frequency unknown—cannot be estimated from available data.
Within each group, adverse effects are presented in decreasing order of severity.

Local reactions: rarely – dry mouth, burning sensation in the oral cavity; frequency unknown – feeling of numbness in the mouth.
Allergic reactions: uncommon – photosensitivity; rarely – hypersensitivity reactions, skin rash, itching; very rarely – angioedema, laryngospasm; frequency unknown – anaphylactic reactions.

If any of the side effects listed in the description worsen or any other side effects not listed in the description are noted, you should immediately inform your doctor.

Overdose

Currently, no cases of overdose of Tantum® Verde have been reported.

Symptoms: When using the drug as described, an overdose is unlikely. If the drug is accidentally ingested, vomiting, abdominal cramps, anxiety, fear, hallucinations, convulsions, ataxia, fever, tachycardia, and respiratory depression may occur.

Treatment: symptomatic; induction of vomiting or gastric lavage using a gastric tube (under medical supervision); provide medical supervision, supportive care and necessary hydration. Antidote unknown.

Storage conditions

In a place protected from light, at a temperature not exceeding 25 °C.

Shelf life

4 years. Do not use after expiration date.

Manufacturer

Aziende Chimique Riunite Angelini Francesco A.C.R.A., Italy